Theriva Biologics Stock (AMEX: TOVX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 137.00 / 601.80K |
Day Range | - - - |
52 Wk Range | 2.67 - 17.11 |
Market Cap | $5.44M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 47 |
Short Interest | 18.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Theriva Biologics (AMEX:TOVX) through any online brokerage.
Other companies in Theriva Biologics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX) and Coeptis Therapeutics (NASDAQ:COEP).
There is no analysis for Theriva Biologics to provide a consensus price target.
The stock price for Theriva Biologics (AMEX: TOVX) is $4.02 last updated September 17, 2024 at 4:13 PM EDT.
There are no upcoming dividends for Theriva Biologics.
Theriva Biologics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Theriva Biologics.
Theriva Biologics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.